Stock Analysis · Bulls vs Bears

Valens Semiconductor VLN

🐂 Bulls vs Bears 🐻Report #312 Oct 2026
★ Willem owns this stock · 2.6% of the portfolio
45
moderate risk▼ −8 vs last
🐂 9vs10 🐻
Bears lead
30%
▲ Chance of the biggest tailwind the forecasts miss
25%
▼ Chance of the biggest headwind the forecasts miss
The verdict

The near-term evidence leans bull: Valens beat the top of its own quarterly revenue guide in 8 of the last 8 quarters. It raised FY26 guidance, and has $83.4M of cash with no debt against an enterprise value of about $104M. The long-term evidence still leans bear: The automotive payoff has slipped a year. The "$10M a year" figure and the 2029 targets have not been repeated. Rival link standards have far broader…

The Bulls vs Bears podcast is being made
Two AI hosts debate this report, NotebookLM-style. It appears here automatically within a few hours.

Written by Claude (Anthropic’s AI) from public sources · Willem owns VLN · AI can make mistakes — numbers in brackets point to the sources · Not financial advice

🐂 Bull arguments 9

  1. 1Eight straight quarters above the top of its own guideStrong
  2. 2Cash is 45% of market value; EV is ~1.3x salesStrong
  3. 3A-PHY is spreading, and Valens' chip work is "completed"Medium
  4. 4Production orders and inventory are building for a stronger H2Medium
  5. 5The 69%-margin AV franchise has fresh products in the marketMedium
  6. 6onsemi pays royalties: a capital-light second route to A-PHY moneyMedium
  7. 7Mercedes revenue rose in H1-26 after two years of declineWeak
  8. 8Overhangs cleared: warrants expired, earn-outs and the customer claim are settledWeak
  9. 9Medical and machine-vision wins give optional extra marketsWeak

🐻 Bear arguments 10

  1. 1The car payoff keeps moving right, and the big targets were droppedHigh
  2. 2Rival link standards have far broader car-maker backing than A-PHYHigh
  3. 3Shares outstanding rose 6.6% in nine months, with no buybackMedium
  4. 4Losses are deep, and break-even needs 38–50% more revenueMedium
  5. 5The FY26 guide needs a 23–31% H2 jump; one customer holds 33% of receivablesMedium
  6. 6The car business is one ageing Mercedes chip with falling marginsMedium
  7. 7The pro-AV end market is soft, and Barco's segment is shrinkingMedium
  8. 8CEO, CFO and auto head all changed; insiders don't buyMedium
  9. 9Revenue fell 31% in the last downturn and still hasn't recoveredMedium
  10. 10China and Hong Kong billings fell 45%; localisation and Israel add riskLow

Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).

Bull case

🐂 Bull #1Eight straight quarters above the top of its own guide

  • The point: On the quarter-by-quarter numbers, management under-promises and over-delivers with unusual consistency. That makes the raised FY26 guide more credible than its back-loading suggests.
  • Evidence:
    • Revenue landed above the top of the quarterly guide range in all 8 quarters from Q3-24 to Q2-26 [3,4,6,28,52]:
      • the average beat versus the midpoint was about +$0.78M (≈4.7%);
      • the largest was Q3-25: $17.3M against a $15.1–15.6M guide.
    • Adjusted EBITDA was better than the guide range in 6 of the 8 quarters and inside the range in the other 2. There were no misses.
    • FY26 guidance went from $75–77M (Feb) to $78–81M (Aug) [3,6].
    • Controls: the auditor (Kesselman & Kesselman, PwC Israel, since 2019) found disclosure controls and internal controls over financial reporting effective, with no material weakness and no restatement [1]. The only 20-F/A (2026-05-13) fixed an auditor consent exhibit [1].
  • Why it matters: A guide raise from a team that beats every quarter is a near-term floor. If Q3 beats by the usual ~4.7%, revenue would be about $22.3M against the $21.3–21.7M guide (estimate, extrapolated from the pattern).
  • 😈 Devil's advocate: The record is a short-range one:
    • FY25 was guided at $71–76M in Nov 2024, cut to $66–71M in Aug 2025 "primarily due to the impact of tariffs", and came in at $70.6M, about 4% below the original midpoint [19,28].
    • The SPAC deck projected $482M of 2026 revenue [53].
    • The 2029 target of $220–300M has been abandoned in favour of single-year guidance [9,19].
    • Interpretation: quarterly guides are set to be beaten; the long-range promises are where the misses are.
  • Verdict: Strong for the next two quarters. It says nothing about the 2027 car ramp.

🐂 Bull #2Cash is 45% of market value; EV is ~1.3x sales

  • The point: The market pays very little for the operating business, so the downside is cushioned by cash.
  • Evidence:
    • At 2026-06-30: $83.4M of cash and deposits ($42.6M cash plus $40.9M deposits), zero debt, and $6.35M of non-current lease liabilities [7].
    • Market value ≈ 108.28M shares × $1.73 (2026-10-09 close) ≈ $187M; enterprise value ≈ $104M (my arithmetic from [7,32]).
    • That is about 1.3x the FY26 guide midpoint and about 1.1x FY27 consensus of $93.0M [29].
    • VLN's own year-end EV/sales: 7.8x (FY21), 4.2x (FY22), 1.35x (FY23), 2.6x (FY24), 0.85x (FY25) [30].
    • Peers, trailing EV/sales: Himax 3.2x, indie Semiconductor 3.9x, Ambarella 6.5x, Allegro 7.2x [30].
    • Short interest is only ~1.5M shares (≈2% of float, ~2 days to cover) and falling [30,31].
  • Why it matters: At H1-26 burn (≈$1.55M a month operating cash outflow) the cash lasts about 54 months [7]. Valens can fund the wait to the 2027 ramp without issuing shares for cash.
  • 😈 Devil's advocate:
    • Cash has fallen from $112.5M (2025-03-31) to $83.4M in five quarters; $19.8M of that went on buybacks in H1-25 [7,8].
    • Stock pay ($6.25M in H1-26) is a second, non-cash cost that the cash figure doesn't show (Bear #3).
    • Interest income is shrinking with the cash pile: $0.71M in Q2-26 versus $2.32M for all of H1-25 [7].
    • FY25's EV/sales of 0.85x shows the stock can get cheaper still.
  • Verdict: Strong as a floor. Weak as an upside driver on its own.

🐂 Bull #3A-PHY is spreading, and Valens' chip work is "completed"

  • The point: MIPI A-PHY is built on Valens' design and is the only open, standards-body car camera link. Valens has four car-maker programmes heading into production in 2027, plus a Mobileye selection.
  • Evidence:
    • Sept 2024: three design wins at "leading European OEMs, which belong to a group of automotive brands", ~500K vehicles a year, "over ten million dollars in annual revenue, for a period of 5-7 years", with Tier-1s "on the camera side and on the System on Chip (SoC) side" [14].
    • Jan 2026: a fourth win with a premium car-maker serving China, start of production (SoP) 2027 [15].
    • Mobileye chose the VA7000 as the sensor-to-compute link for EyeQ6 High programmes "with a group of global automotive brands" [16].
    • Mobileye's FY25 10-K: second-generation SuperVision on EyeQ6 High is "targeting a number of upcoming vehicle launches with VW Group brands Porsche and Audi" [17].
    • On the Q2-26 call, Mobileye's CEO said "2027, we see the Porsche SuperVision program starting to ramp up". It "includes also Audi car models" [18].
    • Valens CEO, Q2-26: "our piece in that very complex puzzle has been completed and delivered. So we have delivered chips to the Tier 1s" [11].
    • MCNEX (camera maker) said the first OEM vehicle SoP is "expected in early 2027" [50].
    • Ecosystem: the first A-PHY production car (Sept 2025) [40], a compliance programme, and interoperability with 7 other A-PHY silicon vendors [1].
  • Why it matters: A camera link, once designed in, ships for 5–7 years. Each programme adds revenue on top of an R&D base that is already being paid for.
  • 😈 Devil's advocate:
    • Interpretation: the "group of brands" wording in both releases fits the VW Group, but no source names VW, Porsche or Audi as Valens customers.
    • The 500K-vehicle figure is far larger than Mobileye's whole SuperVision volume ("slightly below 60,000" units in 2026) [18]. So either the wins are not SuperVision, or 500K is an optimistic OEM forecast.
    • Mobileye itself says the 2027 Porsche ramp is "not a big volume" [18].
    • The first A-PHY production car used Chinese Velinktech chips, not Valens' [40].
    • "Over $10M a year" is about 11% of FY27 consensus revenue, and below the H1-26 automotive segment operating loss of $10.1M [7].
  • Verdict: Medium The standard is real, and the chips are with the Tier-1s. But the size of Valens' share is modest and its timing is controlled by others.

🐂 Bull #4Production orders and inventory are building for a stronger H2

  • The point: The balance sheet shows Valens preparing to ship more, which backs up the guided H2 jump.
  • Evidence:
    • Open purchase orders with manufacturers were $13.3M at 2026-06-30, versus $5.3M at year-end [7].
    • Inventory was $12.5M, up from $10.1M [7].
    • The Q3 guide of $21.3–21.7M is +19% on Q2's $18.1M [6].
    • CEO on Q1: the "second half of 2026 is going to be way stronger than the first half" [10].
  • Why it matters: A fabless chip company doesn't more than double its open wafer and test orders unless customers are forecasting volume.
  • 😈 Devil's advocate:
    • Interpretation: part of the PO build may be test capacity bought to protect car supply ("additional testing facility expenses") rather than extra demand [6,11].
    • Customer forecasts are non-binding [1]. In 2024, customers' inventory digestion cut revenue 31% after a similar build-up [2].
  • Verdict: Medium It supports Q3, not FY27.

🐂 Bull #5The 69%-margin AV franchise has fresh products in the market

  • The point: HDBaseT is the low-cost, zero-delay way to link screens, cameras and PCs inside a room. Its newest chips are now in customers' latest products.
  • Evidence:
    • CIB (AV) segment gross margin: 69.1%, 66.4%, 70.8% and 69.2% over the last four quarters [6,7].
    • CIB revenue rose to $13.1M in Q2-26 from $11.0M in Q1 [6].
    • Q2 growth came "primarily from 2 chipsets, our legacy VS100 family and our cutting-edge VS3000". New products from "Crestron and Extron" hit the market [11].
    • The VS6320 USB-plus-4K reference design built with ODMs "already generated bookings of millions of dollars" [11].
    • Barco chose HDBaseT for its new ClickShare USB-C extension kit [11].
  • Why it matters: Each extra AV dollar brings about 69 cents of gross profit. This segment funds the car bet.
  • 😈 Devil's advocate:
    • H1-26 CIB revenue was still −2.0% year on year ($24.08M vs $24.58M), against the CEO's Q1 call of "around 5 percent growth for CIB across the year" [7,10].
    • Barco's own meeting-room business is shrinking: a "continued double-digit decline in BYOD sell-out" in H1-26 [34].
    • Under the reference design, Valens sells the chips but the ODM keeps the module margin. No new ASP upside, per the CEO [11].
  • Verdict: Medium The margins are proven; the growth is a second-half promise.

🐂 Bull #6onsemi pays royalties: a capital-light second route to A-PHY money

  • The point: Valens can be paid when A-PHY ships inside someone else's image sensor, with no inventory or foundry risk.
  • Evidence:
    • The 6-K says Valens granted onsemi a non-exclusive licence (signed 2026-09-14) to build Valens' A-PHY technology into "a specific next-generation integrated image sensor product … in exchange for certain royalty payments" [12].
    • The licence can be ended only after 10 years, on 180 days' notice. Products already on onsemi's roadmap or commercialised keep paying royalties after termination [12].
    • The press release calls it a "collaboration" aimed at high-volume 3MP car cameras [13].
    • Note: one helper read only the press release and concluded "no royalty". The 6-K cover text wins; I checked it myself.
    • The stock rose from $1.77 to $1.92 that day [32,49].
  • Why it matters: onsemi is a top car image-sensor supplier. A royalty on each sensor is near-100% margin.
  • 😈 Devil's advocate:
    • There are no rates, volumes, sampling dates or production dates [12,13].
    • Each integrated sensor removes a camera-side chip that Valens could otherwise have sold.
    • Sony (IMX828) and OmniVision already integrate A-PHY without any disclosed Valens licence [1].
    • No analyst changed a rating or target on the news [31].
  • Verdict: Medium strategically. Financially it is unsized.

🐂 Bull #7Mercedes revenue rose in H1-26 after two years of decline

  • The point: The old VA6000 car business bridges to A-PHY better than feared.
  • Evidence:
    • Automotive revenue was $10.88M in H1-26 versus $9.31M in H1-25 (+16.9%) [7].
    • On Q1, the CEO confirmed "the uptake comes from Mercedes" [10].
  • Why it matters: A stable bridge means no automotive revenue hole before 2027.
  • 😈 Devil's advocate:
    • Q2 ($5.0M) was already 15% below Q1 ($5.9M) [6].
    • Automotive fell 19.4% in FY24 and 12% in FY25 on fewer Mercedes units and lower prices [1,2].
    • Mercedes passenger-car sales were −8% in Q2-26 with China −30%, and it expects 2026 unit sales "slightly below 2025" (summary only) [43].
  • Verdict: Weak Medium (was Medium). One good quarter inside a declining trend.

🐂 Bull #8Overhangs cleared: warrants expired, earn-outs and the customer claim are settled

  • The point: Several small liabilities and dilution sources from the SPAC and Acroname era are gone.
  • Evidence:
    • 18.16M warrants (for 9.08M shares at $11.50) were suspended from trading on 2026-07-24 and expired on 2026-09-29 [1,24].
      • Interpretation: with the stock near $1.70–1.90 they almost certainly lapsed unexercised. No filing confirms the outcome yet.
    • The Acroname earn-outs: $1.96M paid in March 2026. The $1.5M joint-product earn-out expired unachieved [7].
    • A €2.1M customer claim over a 2024 production batch was settled in July 2026: the insurer paid $1.476M and Valens $250K [7].
    • Ex-CEO Ben-Zvi's $0 "disposal" on 2026-05-12 was a forfeiture of unvested awards on his move from officer to director, per the Form 4 footnote. It was not a sale [26].
  • Why it matters: A cleaner capital structure removes a few small reasons for investors to stay away.
  • 😈 Devil's advocate: The expired warrants were never going to be exercised at $11.50. The real dilution comes from employee equity (Bear #3), which is not going away.
  • Verdict: Weak Housekeeping, not value creation.

🐂 Bull #9Medical and machine-vision wins give optional extra markets

  • The point: The same long-reach link suits endoscopes and factory cameras, which have long product lives and higher prices.
  • Evidence: Three endoscope design wins in 2025, some in FDA approval stages; machine-vision platforms from CIS and imavix [1,54].
  • 😈 Devil's advocate:
    • No revenue is disclosed.
    • The January 2026 efficiency plan focused the company on AV and automotive [20].
    • Stonegate's sponsored-style note puts revenue "several quarters away" (no rating) [55].
  • Verdict: Weak

Bear case

🐻 Bear #1The car payoff keeps moving right, and the big targets were dropped

  • The point: A-PHY revenue has been "next year" for years. The long-range promises have been quietly withdrawn.
  • Evidence:
    • SoP was "in 2026" in the Sept 2024 release [14], then "commercialization expected in 2027" in the 20-F [1].
    • Q4-25 call: revenue "somewhere in the second half of 2027 … we need to put kind of an asterisk on that because we know that automotive projects tend to be delayed" [9].
    • Q2-26: "ramping up during 2027", with timing dependent on Tier-1 and car-maker assembly lines [11].
    • "Over ten million dollars" a year appears only in the 2024 release; it is not in the FY25 20-F or the 2026 calls we could read [1,9,10,11].
    • The 2029 targets set in Nov 2024 (revenue $220–300M, EBITDA margin 15–20%) were replaced by single-year guidance in Feb 2026 [9,19].
    • The SPAC deck projected $482M of revenue for 2026, against a $78–81M guide [53].
  • Why it matters: Each year of delay costs roughly $16M of adjusted EBITDA plus ~$12.5M of stock pay [7,9]. It also pushes back the moment the market pays for the car option.
  • 🛡️ Counter-argument:
    • The slip so far is one year.
    • The chips are delivered to Tier-1s [11].
    • Mobileye independently dates the Porsche/Audi SuperVision ramp to 2027 [18], and MCNEX says "early 2027" [50].
  • Severity: High

🐻 Bear #2Rival link standards have far broader car-maker backing than A-PHY

  • The point: Analog Devices' GMSL is the incumbent. The BMW-led ASA has more named car-makers. Chinese A-PHY vendors compete on price. Valens has not named a single Western car-maker.
  • Evidence:
    • GMSL: a market-research summary puts GMSL at ~44.7% of automotive SerDes chips in 2025 (summary only) [41].
      • The OpenGMSL Association released spec v3.0 on 2026-03-06 [36].
      • It added TE Connectivity Germany and TRIGATE in March 2026, while indie Semiconductor withdrew [35].
      • ADI's automotive revenue was $998M in its Aug-2026 quarter, +16% (summary only) [45].
    • ASA: the ASA lists BMW, Ford, GM, Hyundai Kia, Nio, Renault/Ampere, Stellantis, Volvo Trucks and Xpeng among 150+ members, plus 10 chip suppliers including Sony, Broadcom and OmniVision [37].
      • NXP bought ASA chipmaker Aviva Links [39].
      • Microchip and Marelli showed an ASA-ML display demonstrator on 2026-09-03; no programme or SoP was disclosed [38].
    • A-PHY: the first production car (Lynk & Co 06, Sept 2025) used Velinktech chips [40]. No second Chinese A-PHY car, and no Western car-maker publicly committed to A-PHY, was found.
    • The automotive SerDes market was ~$682M in 2025 (QYResearch summary) [41]. Valens' ~$19M of automotive revenue, almost all of it the old proprietary chip, is ~3% of that.
  • Why it matters: Valens has to win sockets against an incumbent whose automotive revenue is roughly 200 times Valens' (~$4B a year vs ~$19M), and then defend them against cheaper clones of its own standard.
  • 🛡️ Counter-argument:
    • No ASA-ML production car was confirmed either: no teardown or BMW statement ties the Neue Klasse iX3 to ASA-ML.
    • GMSL's "opening up" shows car-makers want multi-vendor options.
    • Mobileye selected Valens after testing [16].
  • Severity: High

🐻 Bear #3Shares outstanding rose 6.6% in nine months, with no buyback

  • The point: Stock pay quietly transfers value to employees, and the buyback that used to offset it has stopped.
  • Evidence:
    • Shares outstanding were 101.58M at 2025-09-30, 103.05M at 2025-12-31, 105.72M at 2026-03-31 and 108.28M at 2026-06-30 [7,8]. That is +6.6% in nine months, ≈8.9% a year.
    • Stock pay was $6.25M in H1-26, or 17.9% of revenue [7].
    • Overhang at 2026-06-30 [7]:
      • 13.15M options (weighted-average strike $1.98; 5.60M at $0.15–0.86);
      • 9.39M RSUs (4.34M granted in H1);
      • fully diluted ≈130.8M, +20.8% on basic shares.
    • An S-8 on 2026-02-25 registered 8,652,834 more shares under the evergreen 2021 plan [25].
    • The 20-F says the company "does not have any active repurchase programs". The $25M programme (9.45M shares, 2024–25) is finished [1].
  • Why it matters: Even if the car ramp arrives on time, value per share grows roughly 6–9% a year slower than the business.
  • 🛡️ Counter-argument:
    • Much of the issuance is old, cheap options being exercised ($2.18M in proceeds in H1) [7].
    • The CEO's 4.0M options (strikes $2.00/$3.25/$4.25) only pay if the stock rises 16–146% [1].
    • There is no need to sell shares for cash.
  • Severity: Medium High.

🐻 Bear #4Losses are deep, and break-even needs 38–50% more revenue

  • The point: Valens is clearly loss-making, and narrowing EBITDA losses hide a much larger GAAP gap.
  • Evidence:
    • GAAP operating margin was −53% in Q1-26 and −44% in Q2-26. GAAP net loss was −$8.3M and −$8.1M [5,7].
    • H1-26 free cash flow was −$9.28M, a −26.5% FCF margin (my arithmetic from [7]).
    • The automotive segment lost $10.1M on $10.9M of revenue in H1-26 [7].
    • CEO: "the company can be EBITDA positive, anywhere between $110 million-$120 million revenue" [9]. Against the FY26 midpoint of $79.5M, that needs +38–50%.
    • Q2→Q3 guide midpoints imply about 32% incremental EBITDA on extra revenue. At that slope, break-even is ≈$31M a quarter, ≈$124M a year (my arithmetic, consistent with the CEO).
    • FY26 adjusted EBITDA is about −$15M to −$16M on my arithmetic (Q1 −5.5 + Q2 −4.2 + Q3 mid −3.1 + Q4 −2.5 to −3.5), versus −$16.9M in FY25. Barely better. No full-year guide exists.
  • Why it matters: Until 2028 at the earliest, every year costs shareholders about $15M of cash-equivalent losses plus ~$12.5M of stock pay.
  • 🛡️ Counter-argument:
    • Opex has fallen from $20.9M (Q4-25) to $19.1M (Q2-26) after the 10% headcount cut [6,20].
    • The CFO expects no significant change from here, so revenue growth falls straight to the bottom line [11].
  • Severity: Medium High.

🐻 Bear #5The FY26 guide needs a 23–31% H2 jump; one customer holds 33% of receivables

  • The point: The raise is back-loaded on AV after a flat first half. Receivables hint that one buyer took a lot of Q2 product.
  • Evidence:
    • H1-26 revenue was $34.96M. The guide needs H2 of $43.0–46.0M (+23–31%), with implied Q4 of ≈$21.4–24.7M [6].
    • Customer A was 13% of H1-26 revenue and 11% of Q2, but 33% of receivables at 2026-06-30, up from 16% at year-end [7].
      • That is ≈$2.9M owed against ≈$2.0M of Q2 sales: about 1.5 quarters of its purchases outstanding, versus ~45 days company-wide (my arithmetic).
    • Customer A went from 2% of revenue (2023) to 13% (2024 and 2025). Its identity is not disclosed [1].
  • Why it matters: A miss would break the one credibility asset management has built (Bull #1).
  • 🛡️ Counter-argument:
    • Total receivables actually fell, to $8.87M from $9.97M [7].
    • The order and inventory build (Bull #4) and named product launches support H2.
  • Severity: Medium

🐻 Bear #6The car business is one ageing Mercedes chip with falling margins

  • The point: Almost all car revenue is a 2021-era proprietary chip sold, through Tier-1s, into Mercedes cars. Its margin is falling.
  • Evidence:
    • Mercedes-Benz contract revenue was $18.4M in 2025, ≈97% of automotive [9].
    • Hungary bill-to revenue went $21.1M (2023) → $12.6M (2024) → $9.0M (2025) [1].
    • Automotive gross margin was 43.2%, 45.9%, 46.2% and then 41.5% in Q2-26, hit by "additional testing facility expenses". The CFO says they will be "with us for the time being" [6,11].
    • No source shows whether any Valens chip continues on Mercedes' new MB.OS platform (CLA 2025 onward).
  • Why it matters: If Mercedes designs the VA6000 out before A-PHY ramps, the automotive segment could lose most of its revenue for a year or more.
  • 🛡️ Counter-argument:
    • The 20-F says the chip is in MBUX "across all Mercedes-Benz passenger car models" through Bosch, Continental and Valeo [1].
    • H1-26 grew (Bull #7).
  • Severity: Medium

🐻 Bear #7The pro-AV end market is soft, and Barco's segment is shrinking

  • The point: Valens' growth engine sells into a slow market that is gradually moving to video over standard IT networks.
  • Evidence:
    • Barco H1-26: orders −4%, sales −8%, EBITDA €26.1M versus €48.0M, and a "continued double-digit decline in BYOD sell-out" in meeting rooms [34].
    • AVIXA cut its five-year pro-AV growth outlook to 3.9% a year (summary only) [42].
    • No 2025–26 share data for HDBaseT versus AV-over-IP (SDVoE, IPMX, Dante AV) was found. The 20-F warns that AI may change meeting-room design [1].
  • Why it matters: If the market grows ~4%, CIB growth must come from share gains and new chips alone.
  • 🛡️ Counter-argument:
    • USB-in-the-room trends favour the VS6320.
    • Crestron and Extron (both private) launched new VS3000-based products in Q2 [11].
  • Severity: Medium

🐻 Bear #8CEO, CFO and auto head all changed; insiders don't buy

  • The point: The team that must deliver the 2027 ramp is new, and nobody inside is buying shares.
  • Evidence:
    • New CEO Salinger since 2025-11-13 [1].
    • CFO Nathanzon resigned (announced 2026-04-13); Pinto-Flomenboim (ex-Arbe) started 2026-08-09 [21].
    • Head of Automotive Segal stepped down; Dean Martin (ex-Harman) started 2026-09-01. He is the third automotive head in about two years [22].
    • Form 4s, March–August 2026: zero open-market buys [26]. Sales were small and under 10b5-1 plans. Examples:
      • director Yarel-Toledano sold ~79.9K shares between $2.06 and $3.53, including at the late-May peak;
      • SVP Operations Boim sold 9.9K at $3.50–3.55 on 05-28/29.
    • No Form 4 since 2026-08-10. No Value Base 13D/A since Nov 2025 (20.26% at 2026-02-10) [1,27].
  • Why it matters: New leaders reset internal plans. The absence of buying after a 50% fall from the May high is a weak negative signal.
  • 🛡️ Counter-argument:
    • The sales are tiny relative to holdings and pre-scheduled.
    • Martin and Salinger both come from Harman and Red Bend, with automotive software backgrounds [22].
    • A new Semtech COO joined the board on 2026-09-14 [23].
  • Severity: Medium Low.

🐻 Bear #9Revenue fell 31% in the last downturn and still hasn't recovered

  • The point: Valens is a cyclical, turns-based chip supplier with little order visibility.
  • Evidence:
    • Revenue was $84.2M (2023), $57.9M (2024, −31%) and $70.6M (2025) [1,2].
      • In 2024, CIB fell 36.8% as customers worked down COVID-era inventory and shortened their purchase-order lead times [2].
      • CIB gross margin fell from 77.1% to 71.0% on under-absorption [2].
    • FY26's guide midpoint is still about 6% below 2023 revenue.
    • There is no disclosed backlog. Opening backlog is "typically lower" than the quarter's sales [1].
  • Why it matters: A new inventory cycle in pro-AV or cars could undo a year of progress within two quarters.
  • 🛡️ Counter-argument: Channel inventory was reset in 2024. Peers' automotive revenue is growing again: ADI +16%, NXP +12% (summaries only) [45].
  • Severity: Medium

🐻 Bear #10China and Hong Kong billings fell 45%; localisation and Israel add risk

  • The point: A large billing region is shrinking. China pushes car-makers to local chips. Valens' R&D sits in Israel.
  • Evidence:
    • China plus Hong Kong was ≈$19.7M of FY25 billings (28%) [1].
    • In H1-26 it fell to $5.36M from $9.67M (China −51%, HK −39%) [7].
    • The 20-F flags possible BIS export-rule expansion to China [1].
    • Chinese car-makers target domestic chips (secondary source) [44]. Velinktech, Rsemi and Southchip are local SerDes vendors [40].
    • Israel holds an election on 2026-10-27 [51]. The 20-F adds Israel-Iran conflict risk (June 2025 and Feb 2026 operations) [1].
    • PFIC status for 2026 remains "uncertain"; the wording is unchanged from last year [1].
  • Why it matters: If the China decline is real demand loss rather than a billing shift, it removes a quarter of the base.
  • 🛡️ Counter-argument:
    • Interpretation: CIB fell only 2% and automotive rose 17% in H1, while "other" regions rose $3.8M and the US $0.9M [7]. So the China/HK drop looks more like AV distributor or ODM billing moving between entities than lost sales. No company comment confirms this.
    • Management reported "no effect of tariffs" in Q1 [10].
  • Severity: Low Medium (was flagged as a bigger unknown last time).

Tailwinds NOT in the forecasts

Baseline:

  • FY26 guide: $78–81M. FY26 consensus: $78.5M revenue, EPS −$0.13 (3 analysts) [29].
  • FY27 consensus: $93.0M revenue (+18.5%), EPS −$0.08 (analyst count not shown; 2 publish targets) [29,31].
  • No FY28 consensus and no segment split are public.

Per-share maths uses ~110M shares for FY27 (estimate: 108.3M plus continued issuance), with incremental gross margins of 69% for AV and ~45% for automotive [6,7].

  • AV (CIB) revenue beats FY27 consensus by ~$6M — 30% chance by FY27 results (Feb 2028)

    • Impact on revenue: +$6M, +6.5% vs FY27 consensus of $93.0M

    • Impact on EPS: +$0.038 per share. Against consensus of −$0.08 that halves the loss (≈+47%)

    • How we got the number (estimate): $6M × 69% CIB gross margin (opex flat per CFO) ÷ 110M shares ≈ +$0.038

    • Expected value: 0.30 × $0.038 ≈ +$0.011 per share

    • What it is: VS3000/VS6320 design-ins and the ODM reference design lift FY27 AV revenue about $6M above what consensus implies (estimate: FY26 AV ≈ $58M = $79.5M guide midpoint − ~$21M automotive).

    • Why it's not priced in: consensus FY26 ($78.5M) sits below the guide midpoint ($79.5M), despite 8/8 beats. Interpretation: analysts are not modelling the beat pattern.

    • Trigger to watch: Q3 CIB above $16M, and a Q4 guide above $23M.

    • Why this probability: The beat record argues for upside. Flat H1 AV and a shrinking Barco BYOD segment argue against.

  • A fifth A-PHY car-maker win, or a named Mobileye-programme car-maker using Valens — 33% chance by end-2027

    • Impact on revenue: about +$10M a year from the first full production year, likely FY29 (no FY29 consensus exists, so the % is not computable). FY27 impact: ~$0.

    • Impact on EPS: about +$0.04 per share in FY29

    • How we got the number (estimate): a programme sized like the 2024 wins, $10M × 45% automotive gross margin ÷ 112M shares ≈ +$0.04

    • Expected value: 0.33 × $0.04 ≈ +$0.013 per share (FY29)

    • What it is: a new programme at a US, Japanese or Korean car-maker, or a named EyeQ6H brand.

    • Why it's not priced in: consensus covers only the existing four wins, if any automotive growth at all.

    • Trigger to watch: a 6-K design-win release; Dean Martin's first public comments; Mobileye naming EyeQ6H customers at its Q3 (~2026-10-22, unconfirmed) [18].

    • Why this probability: No new win in the nine months since January. But the CEO says several more OEM evaluations are underway [11], and Mobileye pushes the link to more brands.

  • A second A-PHY licensee, or disclosed onsemi royalty income — 25% chance within 36 months

    • Impact on revenue: not quantifiable. No royalty rate, sensor volume or SoP has been disclosed for onsemi [12,13], so there is no anchor.

    • Impact on EPS: not quantifiable, for the same reason. Royalties carry near-100% margin, so each $1M ≈ +$0.009 per share.

    • How we got the number (estimate): $1M ÷ 110M shares ≈ $0.009 per $1M of royalty

    • Expected value: not quantifiable

    • What it is: another sensor or SoC maker licensing Valens' A-PHY design.

    • Why it's not priced in: no model includes royalties.

    • Trigger to watch: a licensing revenue line; a 6-K like the 2026-09-22 one.

    • Why this probability: Sony and OmniVision already integrate A-PHY without a disclosed licence, which narrows the pool.

  • Takeover bid at a premium — 10% chance within 36 months

    • Impact on revenue: not applicable

    • Impact on EPS: not applicable. Price impact estimate: a 40–60% premium on $1.73 ≈ $2.40–2.80.

    • How we got the number (estimate): typical small-cap chip premiums; no specific source

    • Expected value: not quantifiable on EPS

    • What it is: an AV or auto-chip buyer pays for the standard-anchored IP plus $83M of cash.

    • Why it's not priced in: no process has been reported.

    • Trigger to watch: a Value Base 13D/A; Israeli press reports.

    • Why this probability: Cheap EV and a CEO with two prior trade sales argue for it. No insider buying and no activist filing argue against.

Headwinds NOT in the forecasts

  • Mercedes VA6000 volumes fall ~40% before A-PHY ramps — 25% chance by FY27

    • Impact on revenue: −$8M, −8.6% vs FY27 consensus of $93.0M

    • Impact on EPS: −$0.031 per share (the loss widens by ~38% vs −$0.08)

    • How we got the number (estimate): ~$20M base × 40% = $8M × 42% automotive gross margin ÷ 110M shares ≈ −$0.031

    • Expected value: 0.25 × −$0.031 ≈ −$0.008 per share

    • What it is: Mercedes' MB.OS platforms drop the 2021-era link, or unit sales keep falling (China −30% in Q2-26) [43].

    • Why it's not priced in: FY27 consensus growth of +$13.5M implies a stable or growing automotive base.

    • Trigger to watch: quarterly automotive revenue below $4.5M.

    • Why this probability: Two straight years of decline before 2026, and no evidence either way on MB.OS. But H1-26 rose.

  • A-PHY ramp slips past 2027, or starts well below "$10M a year" — 45% chance by end-2027

    • Impact on revenue: −$4M, −4.3% vs FY27 consensus

    • Impact on EPS: −$0.016 per share (−20% vs −$0.08)

    • How we got the number (estimate): we assume ~$4M of A-PHY revenue in FY27 consensus (estimate; analysts' split is not public) × 45% gross margin ÷ 110M shares ≈ −$0.016

    • Expected value: 0.45 × −$0.016 ≈ −$0.007 per share

    • What it is: Tier-1 or car-maker line delays push meaningful VA7000 revenue into 2028.

    • Why it's not priced in: consensus assumes a ramp "during 2027".

    • Trigger to watch: the Q4-25-style "asterisk" language returning; "2028" appearing in the Q3 or Q4 call.

    • Why this probability: It has slipped once already, and the CEO himself flagged delay risk. Mobileye's matching 2027 Porsche timing keeps this just below a coin flip.

  • The H2-26 AV jump falls short, and Customer A destocks — 20% chance by Q4-26 results

    • Impact on revenue: −$5M, −5.4% vs FY27 consensus (FY26 would also miss the guide by ~$2–3M)

    • Impact on EPS: −$0.031 per share

    • How we got the number (estimate): $5M × 69% CIB gross margin ÷ 110M shares ≈ −$0.031

    • Expected value: 0.20 × −$0.031 ≈ −$0.006 per share

    • What it is: Q2's large shipment to Customer A (33% of receivables) proves to be a stocking order that unwinds.

    • Why it's not priced in: consensus sits on the guide; the receivables concentration is not discussed publicly.

    • Trigger to watch: Q3 revenue below $21.3M; Customer A's receivables share at 2026-09-30.

    • Why this probability: 8/8 beats and the PO build argue against a miss. Flat H1 AV and the receivable spike argue for one.

  • Chinese A-PHY clones and OpenGMSL cap Valens' share and price — 35% chance within 36 months

    • Impact on revenue: not quantifiable for FY27, because it bites from FY28 onward on programmes not yet awarded.

    • Impact on EPS: not quantifiable

    • How we got the number (estimate): no basis; the A-PHY revenue split is not disclosed

    • Expected value: not quantifiable

    • What it is: Velinktech, Rsemi and Southchip take Chinese sockets, while Western car-makers stay on GMSL or move to ASA.

    • Why it's not priced in: analysts treat A-PHY adoption as Valens adoption.

    • Trigger to watch: named rival production wins; automotive gross margin staying below 45%.

    • Why this probability: The first production car went to a rival, and the ASA has more named car-makers than A-PHY.

  • Broader US chip tariffs or China export rules — 15% chance within 36 months

    • Impact on revenue: not quantifiable. US billings were $9.6M in FY25 [1], but the end demand is global and pass-through is unknown.

    • Impact on EPS: not quantifiable

    • How we got the number (estimate): no basis

    • Expected value: not quantifiable

    • What it is: Section 232 extended to legacy chips, or new BIS limits on China.

    • Why it's not priced in: Valens' legacy products are exempt today [1].

    • Trigger to watch: a new tariff proclamation.

    • Why this probability: Policy is volatile, but no new semiconductor step since January 2026 was found.

Investment Risk Score: 45/100 (moderate)

# Factor Weight Measured value Score Why
1 Liquidity & funding runway 15% $83.4M cash+deposits, $0 debt, no credit line needed; H1-26 op. cash flow −$8.98M (≈$1.55M/month) → runway ≈54 months; no going-concern language 46 Runway is well over 36 months, but cash flow is negative and the pile is shrinking ~$9–12M a year.
2 Leverage 10% Net cash ≈$83M; leases $6.35M non-current 8 No financial debt at all.
3 Dilution (last 12 months + overhang) 10% Shares 101.58M→108.28M in 9 months (+6.6%, ≈8.9%/yr); fully diluted +20.8%; evergreen S-8 +8.65M; no buyback; warrants expired 55 High in the +3–10% band, with a large option and RSU overhang and nothing offsetting it.
4 Profitability 10% H1-26 FCF margin ≈−26.5%; GAAP op margin −44% (Q2); adj. EBITDA −$4.2M (Q2) → −$3.1M guide (Q3); break-even at $110–120M revenue 68 Clearly loss-making but improving; break-even is ≥2 years away.
5 Revenue quality & concentration 10% Top customer 13% (H1-26), top 3 31% (FY25); Mercedes ≈26% of revenue via Tier-1s; 100% purchase-order chip sales, no backlog; one customer 33% of receivables 45 The direct customer spread is fine, but the end-customer exposure to Mercedes and turns-based selling push it to mid-band.
6 Execution & track record 10% 8/8 quarterly revenue beats, EBITDA 6/8 better and 2 in range; FY25 annual guide cut; SoP 2026→2027; 2029 targets dropped; ICFR effective 45 Excellent short-range record, serial long-range misses: "mixed" overall.
7 Competitive position & disruption 10% GMSL ~45% protocol share; ASA has 9+ named OEMs; first A-PHY car went to Velinktech; no Western OEM named for Valens; AV-over-IP substitution 62 Contested, tilting to losing ground in cars. HDBaseT is a strong but slow niche.
8 Cyclicality & commodity/macro sensitivity 10% Revenue −31% in 2024 on inventory correction; still ~6% below 2023 at the FY26 midpoint; Barco BYOD sell-out falling double digits 55 Cyclical: turns business with no backlog in two cyclical end markets.
9 Regulatory, legal & geopolitical 5% China+HK 28% of FY25 billings (−45% H1-26); Israel R&D, war and election 2026-10-27; PFIC "uncertain"; no material litigation; tariffs exempt today 45 Material but contained.
10 Valuation & expectations 10% EV ≈$104M ≈1.3x FY26 guide, ≈1.1x FY27 consensus; peers 3–7x; short interest ≈2% of float; 2 analysts with $4 targets; stock −35% on 2026-06-05 vs SOX −10% 22 Cheap against history and peers, with low short interest. The high beta stops it scoring lower.

Overall: weighted average = 0.15×46 + 0.10×8 + 0.10×55 + 0.10×68 + 0.10×45 + 0.10×45 + 0.10×62 + 0.10×55 + 0.05×45 + 0.10×22 = 44.95 → 45.

Change vs last: −8, mostly from the method change:

  • The old six-area score of 53 lumped balance-sheet strength into "financial health & dilution" (42).
  • The v3 method scores leverage separately (8, net cash) and valuation separately (22, cheap). Those two factors pull the total down.

On the facts:

  • Risk went down:
    • the 8/8 beat record is better than the "four in a row" we had;
    • the warrants are gone;
    • the Ben-Zvi "disposal" was a forfeiture, not a sale;
    • the China drop looks like a billing shift.
  • Risk went up:
    • dilution is faster than measured last time (+6.6% in nine months versus +2.8% in five);
    • competition is firmer, with ASA's broad OEM list and no Western A-PHY OEM named.

Ranking check: At 45, VLN sits between AVGO (34) and GENI (48):

  • it is riskier than AVGO, because it loses money and is sub-scale in contested markets;
  • it is safer than GENI, because GENI carries net debt of ~4.2x EBITDA and faster dilution, while Valens has no debt and ~4.5 years of runway.

Conclusion

  • What you are really betting on: that the A-PHY standard Valens designed becomes a meaningful share of car camera links from 2027, and that Valens gets paid for it, through VA7000 chips or royalties like onsemi's. Meanwhile the AV business and $83M of cash carry the company and cap the downside.
  • The 2–3 things that will decide the outcome:
    1. Whether the four A-PHY programmes produce real revenue in 2027, and the European wins are confirmed as the Porsche/Audi Mobileye programmes or something larger.
    2. Whether Mercedes VA6000 revenue holds until then.
    3. Whether AV growth and cost discipline reach break-even (~$110–124M of revenue) before stock pay dilutes holders by another 15–20%.
  • Signposts:
    • Confirming the bull case:
      • Q3-26 revenue ≥ $22M (the usual beat), CIB ≥ $16M, and Customer A's receivables share back below 20%;
      • a fifth A-PHY win, or any named car-maker or Tier-1;
      • royalty income disclosed, or a second licensee;
      • automotive revenue rising quarter on quarter through 2027.
    • Breaking the bull case:
      • "2028" or "asterisk" language on the A-PHY ramp;
      • a Q3 or Q4 revenue miss, the first in nine quarters;
      • automotive revenue below $4.5M a quarter;
      • shares outstanding above 112M by mid-2027 with no buyback, or cash below $70M.
  • New since the last report:
    • The beat record is 8 of 8 quarters (Q3-24 to Q2-26), not 4. But the FY25 annual guide was cut, and the 2029 targets are gone.
    • Dilution is faster than measured: +6.6% in nine months, with a 20.8% fully diluted overhang. The 18.16M warrants expired on 2026-09-29.
    • Mobileye's 10-K and Q2 call tie second-generation SuperVision on EyeQ6H to Porsche and Audi, ramping in 2027 at "not a big volume". That fits Valens' "group of brands", but no source names Valens. The ASA camp has a much broader list of named car-makers than A-PHY.

Open questions & data gaps

  • Who are the A-PHY customers? The VW-group fit is interpretation only, and the 500K-vehicle figure doesn't match Mobileye's SuperVision volumes. This matters a lot for Bull #3 and Bear #1.
  • Mercedes on MB.OS: not found. This matters a lot for 2027.
  • Customer A: identity and whether the 33% receivable was collected. The Q3 interim notes will show it.
  • Analyst models: FY27 analyst count, the A-PHY revenue assumption and FY28 consensus are paywalled or not found. The A-PHY sizing in the headwind is my estimate.
  • onsemi royalty economics: not disclosed.
  • Call transcripts: all quotes come from third-party transcripts (Motley Fool/Webull, Yahoo, MarketBeat), which were partial for Q4-25 and Q1-26. The verbatim Q&A was not available.
  • Unexplained stock moves: the +44% on 2026-04-30 had no filing or news found. The −35% on 2026-06-05 coincided with a −10.3% SOX day [33]; no Valens-specific cause was found.
  • Warrant expiry: almost certainly unexercised, but no filing confirms it.
  • Q3-26 date: not announced. Last year's Q3 came on 2025-11-12, with the date announced on 2025-10-22 [47].
Sources
  1. Valens Semiconductor Form 20-F for FY2025 — SEC EDGAR — 2026-02-25 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026020108/ea0276757-20f_valens.htm
  2. Valens Semiconductor Form 20-F for FY2024 — SEC EDGAR — 2025-02-26 — https://www.sec.gov/Archives/edgar/data/1863006/000121390025017221/ea0231157-20f_valenssemi.htm
  3. Valens Q4 and FY2025 results (6-K Ex. 99.1) — SEC EDGAR — 2026-02-25 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026020111/ea027798201ex99-1_valens.htm
  4. Valens Q1 2026 results (6-K Ex. 99.1) — SEC EDGAR — 2026-05-13 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026055461/ea029011601ex99-1.htm
  5. Valens Q1 2026 interim financial statements (6-K Ex. 99.1) — SEC EDGAR — 2026-05-13 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026055459/ea029011501ex99-1.htm
  6. Valens Q2 2026 results (6-K Ex. 99.1) — SEC EDGAR — 2026-08-12 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026088012/ea030137701ex99-1.htm
  7. Valens interim financial statements, six months to 2026-06-30 (6-K Ex. 99.1) — SEC EDGAR — 2026-08-12 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026088015/ea030056301ex99-1.htm
  8. Valens Q3 2025 interim financial statements (6-K Ex. 99.1) — SEC EDGAR — 2025-11-12 — https://www.sec.gov/Archives/edgar/data/1863006/000121390025108641/ea026416401ex99-1_valens.htm
  9. Valens Q4 2025 earnings call transcript (partial) — MarketBeat — 2026-02-26 — https://www.marketbeat.com/earnings/reports/2026-2-26-valens-semiconductor-stock/
  10. Full transcript: Valens Semiconductor Q1 2026 earnings call — Yahoo Finance — 2026-05-13 — https://finance.yahoo.com/news/full-transcript-valens-semiconductor-q1-161154564.html
  11. Valens Q2 2026 earnings call transcript (Motley Fool copy) — Webull — 2026-08-12 — https://www.webull.com/news/15429283433653248
  12. Form 6-K: licence agreement with Semiconductor Components Industries (onsemi), dated 2026-09-14 — SEC EDGAR — 2026-09-22 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026101917/ea0306060-6k_valens.htm
  13. Valens to collaborate with onsemi on a cost-optimized integrated sensor based on MIPI A-PHY (6-K Ex. 99.1) — SEC EDGAR — 2026-09-22 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026101917/ea030606001ex99-1.htm
  14. Valens announces three automotive design wins from leading European OEMs (6-K Ex. 99.1) — SEC EDGAR — 2024-09-17 — https://www.sec.gov/Archives/edgar/data/1863006/000121390024079168/ea021447801ex99-1_valens.htm
  15. Valens secures 4th VA7000 MIPI A-PHY design win (6-K Ex. 99.1) — SEC EDGAR — 2026-01-06 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026001586/ea027173701ex99-1_valens.htm
  16. Mobileye selects Valens' VA7000 MIPI A-PHY chipsets — Valens — 2025-04-02 — https://www.valens.com/newsroom/mobileye-selects-valens-semiconductors-va7000-mipi-a-phy-chipsets-for-automated-and-autonomous-driving-projects
  17. Mobileye Global Form 10-K for FY2025 — SEC EDGAR — 2026 — https://www.sec.gov/Archives/edgar/data/1910139/000110465926014300/mbly-20251227x10k.htm
  18. Mobileye Global Q2 2026 earnings call transcript — MarketBeat — 2026-07-24 — https://www.marketbeat.com/earnings/reports/2026-7-24-mobileye-global-inc-stock/
  19. Valens Investor Day release: 2029 targets and FY25 guide (6-K Ex. 99.1) — SEC EDGAR — 2024-11-12 — https://www.sec.gov/Archives/edgar/data/1863006/000121390024096172/ea022074301ex99-1_valens.htm
  20. Valens announces operational efficiency plan (6-K Ex. 99.1) — SEC EDGAR — 2026-01-28 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026008503/ea027423101ex99-1_valens.htm
  21. Valens appoints Karine Pinto-Flomenboim as CFO (6-K Ex. 99.1) — SEC EDGAR — 2026-06-22 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026070356/ea029540401ex99-1.htm
  22. Form 6-K: Head of Automotive stepping down; Valens appoints Dean Martin — SEC EDGAR / PR Newswire — 2026-07-20 and 2026-07-31 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026079603/ea0298166-6k_valens.htm ; https://www.sec.gov/Archives/edgar/data/1863006/000121390026083583/ea029987801ex99-1.htm
  23. Valens appoints Asaf Silberstein to its board (6-K Ex. 99.1) — SEC EDGAR — 2026-09-14 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026099736/ea030483801ex99-1.htm
  24. Form 6-K: warrant delisting and expiry — SEC EDGAR — 2026-07-24 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026081357/ea0299180-6k_valens.htm
  25. Form S-8 (8,652,834 additional shares, 2021 plan) — SEC EDGAR — 2026-02-25 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026020403/ea0277982-s8_valens.htm
  26. Valens insider Forms 3 and 4, March–September 2026 (incl. Ben-Zvi accession 0001976408-26-000433) — SEC EDGAR — 2026-03 to 2026-09 — https://data.sec.gov/submissions/CIK0001863006.json
  27. Schedule 13D/A (Value Base, Amendment 3) — SEC EDGAR — 2025-11-24 — https://www.sec.gov/Archives/edgar/data/1863006/000117891325003944/primary_doc.xml
  28. Valens Q2 2025 results incl. FY25 guide cut (6-K Ex. 99.1) — SEC EDGAR — 2025-08-06 — https://www.sec.gov/Archives/edgar/data/1863006/000121390025072331/ea025167802ex99-1_valens.htm
  29. VLN analyst forecast — StockAnalysis (S&P Global data) — checked 2026-10-12 — https://stockanalysis.com/stocks/vln/forecast/
  30. VLN statistics, ratios and peer statistics — StockAnalysis — checked 2026-10-12 — https://stockanalysis.com/stocks/vln/statistics/
  31. VLN analyst ratings (Needham 2026-08-12, Oppenheimer 2026-08-13, Roth 2026-02-26) — TipRanks — checked 2026-10-12 — https://www.tipranks.com/stocks/vln/forecast
  32. VLN daily price history — Yahoo Finance chart data — checked 2026-10-12 — https://query1.finance.yahoo.com/v8/finance/chart/VLN
  33. Philadelphia Semiconductor Index tumbles 10.3% — Herald Corp — 2026-06-06 — https://biz.heraldcorp.com/article/10777324
  34. Barco half-year results 2026 — Barco — 2026-07-15 — https://www.vfb.be/Media/Default/pdf/2026%2007%2015%20-%20%20PR%201H26%20Results%20(EN)%20(1).pdf
  35. Notice pursuant to the National Cooperative Research and Production Act — OpenGMSL Association — Federal Register — 2026-03-26 — https://www.govinfo.gov/content/pkg/FR-2026-03-26/pdf/2026-05924.pdf
  36. OpenGMSL Association releases Specification v3.0 — OpenGMSL — 2026-03-06 — https://www.opengmsl.org/news/opengmsl-association-releases-specification-v3-0-enabling-interoperable-gmsl2-3-ecosystem/
  37. ASA successfully establishes multi-vendor market for camera and display connectivity — Automotive SerDes Alliance — 2024-06-03 — https://auto-serdes.org/news/asa-successfully-establishes-multi-vendor-market-for-camera-and-display-connectivity-953/
  38. Microchip and Marelli pioneer open-standard display connectivity solution — Microchip IR — 2026-09-03 — https://ir.microchip.com/news-events/press-releases/detail/1412/microchip-and-marelli-pioneer-open-standard-display-connectivity-solution-for-software-defined-vehicles
  39. NXP to acquire Aviva Links — NXP — 2024-12-17 — https://www.nxp.com/company/about-nxp/newsroom/NW-NXP-TO-ACQUIRE-AUTOMOTIVE-NETWORKING
  40. MIPI A-PHY reaches milestone of first SerDes standard to enter mass production — MIPI Alliance — 2025-09-22 — https://www.mipi.org/press-releases/mipi-a-phy-reaches-milestone-of-first-serdes-standard-to-enter-mass-production-with-global-automotive-oem
  41. Automotive SerDes chip market (QYResearch; summary only) — DRI — 2026-02-27 — https://www.dri.co.jp/auto/report/qyr/260227-automotive-serdes-chip.html
  42. AVIXA research forecasts pro AV industry to reach $402 billion by 2030 (summary) — Digital Signage Pulse — 2025-09-04 — https://digitalsignagepulse.com/news/avixa-research-forecasts-pro-av-industry-set-to-reach-402-billion-by-2030/
  43. Mercedes-Benz Q2 deliveries decline, China −30% (summary only) — chinaevhome — 2026-07-08 — https://chinaevhome.com/2026/07/08/mercedes-benz-q2-deliveries-decline-6-hit-by-30-china-sales-drop/
  44. China's automakers to localise chips (Nikkei relay; secondary) — TechNews — 2025-06-18 — https://technews.tw/2025/06/18/china-automakers-will-achieve-100-localization-of-chips-by-2026/
  45. ADI reports record fiscal Q3 2026 results (summary only; fetch failed) — Analog Devices — 2026-08-19 — https://www.analog.com/en/newsroom/press-releases/2026/8-19-2026-adi-reports-record-fiscal-3q2026-financial-results.html
  46. Valens Semiconductor: Uninspiring results, but valuation has reset (upgrade to Hold; summary only) — Seeking Alpha — ~2026-03-24 — https://seekingalpha.com/article/4885296-valens-semiconductor-uninspiring-results-but-valuation-has-reset-upgrade
  47. Valens to announce Q3 2025 results on November 12, 2025 — Valens IR — 2025-10-22 — https://investors.valens.com/news-and-events/news/news-details/2025/Valens-Semiconductor-to-Announce-Third-Quarter-2025-Financial-Results-on-November-12-2025/default.aspx
  48. Why Valens Semiconductor stock soared today — Motley Fool — 2026-05-13 — https://www.fool.com/investing/2026/05/13/why-valens-semiconductor-stock-soared-today/
  49. VLN stock jumps 8% premarket on onsemi deal — Stocktwits — 2026-09-22 — https://stocktwits.com/news-articles/markets/equity/vln-stock-jumps-8-premarket-onsemi-deal-targets-high-volume-auto-cameras/cZMPNlZRBeV
  50. Valens/MCNEX A-PHY camera release (6-K Ex. 99.1) — SEC EDGAR — 2026-02-18 — https://www.sec.gov/Archives/edgar/data/1863006/000121390026017686/ea027725401ex99-1_valens.htm
  51. Israel's economy prospers despite years of war, but prices worry voters — Al Jazeera — 2026-10-10 — https://www.aljazeera.com/economy/2026/10/10/israels-economy-prospers-despite-years-of-war-but-prices-worry-voters
  52. Valens Q3 2024 and Q2 2024 results (6-K Ex. 99.1) — SEC EDGAR — 2024-11-06 and 2024-08-07 — https://www.sec.gov/Archives/edgar/data/1863006/000121390024094760/ea021979001ex99-1_valens.htm ; https://www.sec.gov/Archives/edgar/data/1863006/000121390024065892/ea021058302ex99-1_valens.htm
  53. PTK Acquisition / Valens investor presentation (8-K Ex. 99.2) — SEC EDGAR — 2021-05 — https://www.sec.gov/Archives/edgar/data/1797099/000119312521171832/d151475dex992.htm
  54. Valens Q4 2025 earnings presentation — Valens IR — 2026-02 — https://s28.q4cdn.com/438644442/files/doc_financials/2025/q4/Q4_2025-earnings-PPT_Feb-2026.pdf
  55. Stonegate Capital Partners updates coverage on Valens (1Q26) — Newsfile — 2026-05-13 — https://www.newsfilecorp.com/release/297373/Stonegate-Capital-Partners-Updates-Coverage-on-Valens-Semiconductor-Ltd.-VLN-1Q26
All VLN Bulls vs Bears reports
Disclaimer. AI-generated research and podcast (Claude by Anthropic, voices by Google Gemini) for educational purposes — not financial advice and not a recommendation to buy or sell. Willem (MR.INVEST) owns this stock. Check the company’s own filings before making any decision.
← All Bulls vs Bears reports